FindTrial
Sign In

Adverse drug reactions of tigecycline and changes of intestinal flora

Adverse drug reactions of tigecycline and changes of intestinal flora

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037263
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse drug reactions

Interventions

ADR group vs NON-ADR group:NIl

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who need tigecycline in treatment (2) Age >= 18 years; (3) Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Those suffering from intestinal diseases; (2) Have had major gastrointestinal surgery within 5 years; (3) Abnormal liver functions.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;—

Countries

China

Contacts

Public ContactLi Dongjie

Shanghai Tenth People's Hospital

Ldjbio@126.com+86 18917687625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026